Methyltestosterone
Metandren, Oreton Methyl (methyltestosterone) is a small molecule pharmaceutical. Methyltestosterone was first approved as Metandren on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, erectile dysfunction, and hypogonadism in the USA. The pharmaceutical is active against androgen receptor.
Trade Name | Metandren, Oreton Methyl |
---|---|
Common Name | Methyltestosterone |
Indication | breast neoplasms, delayed puberty, erectile dysfunction, hypogonadism |
Drug Class | Steroids (androgens, anabolics) |